|
CFLAR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.852200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.024000E-01 |
| Normal-vs-Stage2 |
1.578610E-01 |
| Normal-vs-Stage3 |
9.650000E-01 |
| Normal-vs-Stage4 |
8.124300E-02 |
| Stage1-vs-Stage2 |
5.538300E-02 |
| Stage1-vs-Stage3 |
7.035600E-01 |
| Stage1-vs-Stage4 |
3.733600E-01 |
| Stage2-vs-Stage3 |
3.021800E-01 |
| Stage2-vs-Stage4 |
4.021800E-02 |
| Stage3-vs-Stage4 |
3.787200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.802200E-01 |
| Normal-vs-AfricanAmerican |
3.377000E-01 |
| Normal-vs-Asian |
1.514420E-01 |
| Caucasian-vs-AfricanAmerican |
3.746200E-01 |
| Caucasian-vs-Asian |
3.700600E-01 |
| AfricanAmerican-vs-Asian |
5.268600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.056200E-01 |
| Normal-vs-Female |
9.577800E-01 |
| Male-vs-Female |
6.863400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.128000E-01 |
| Normal-vs-Extreme_Weight |
1.772240E-01 |
| Normal-vs-Obese |
4.921400E-01 |
| Normal-vs-Extreme_Obese |
5.415400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.742400E-01 |
| Normal_Weight-vs-Obese |
1.470760E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.508600E-01 |
| Extreme_Weight-vs-Obese |
6.361700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.578400E-01 |
| Obese-vs-Extreme_Obese |
3.649600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.790600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.806200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.553600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.082800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.596800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.933200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.222200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.200400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.166600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.889800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.247600E-01 |
| Normal-VS-Type2 PRCC |
9.767000E-01 |
| Normal-VS-KIRP CIMP |
2.884800E-01 |
| Normal-VS-Unclassified PRCC |
8.607600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.615000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.382600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.128400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.343000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.420190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.348200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.879900E-02 |
| Normal-vs-N1 |
7.865200E-01 |
| Normal-vs-N2 |
3.006000E-01 |
| N0-vs-N1 |
1.291600E-01 |
| N0-vs-N2 |
1.587370E-01 |
| N1-vs-N2 |
5.999600E-01 |
|
|
